When Floridians are injured by a defective product—whether a medical device, automobile, or household item—they often turn to product liability law to seek justice. But even when a product causes clear harm, one powerful legal concept can bar recovery: federal preemption.
Federal preemption occurs when federal law overrides or “preempts” state laws, meaning a state-based claim cannot proceed because it conflicts with federal regulation. In the context of Florida product liability claims, preemption can significantly limit a consumer’s ability to recover damages from a manufacturer.
This article explains what preemption is, how it applies in Florida product claims, and what injured consumers should know when federal law stands in the way of justice.
The Supremacy Clause of the U.S. Constitution (Article VI, Clause 2) establishes that federal law is the “supreme law of the land.” When Congress enacts legislation that occupies a specific field, or when federal regulations conflict with state laws, the federal rule takes priority.
In the context of product liability, preemption arises when products are regulated by federal agencies such as:
The Food and Drug Administration (FDA) – for drugs, medical devices, and food.
The National Highway Traffic Safety Administration (NHTSA) – for motor vehicles.
The Consumer Product Safety Commission (CPSC) – for consumer products.
If these agencies impose comprehensive federal standards, manufacturers may argue that they cannot be sued under state law because doing so would conflict with federal oversight.
Courts recognize three main types of preemption relevant to Florida product claims:
This occurs when Congress explicitly states in a statute that federal law preempts state law.
For example, the Medical Device Amendments (MDA) to the Food, Drug, and Cosmetic Act (FDCA) contain an express preemption clause. It bars states from imposing requirements “different from or in addition to” federal requirements for medical devices that received premarket approval (PMA).
If a pacemaker or hip implant has PMA from the FDA, a Florida plaintiff may be prevented from suing the manufacturer under traditional state law theories, like negligence or strict liability.
Implied preemption arises when federal regulation is so comprehensive that it “occupies the field” and leaves no room for state law—or when compliance with both federal and state law is impossible.
For example, if the FDA has strict labeling requirements for a prescription drug, a plaintiff cannot claim that the manufacturer should have used a different label unless that label was FDA-approved. Doing so would directly conflict with federal law.
This occurs when complying with both state and federal law is impossible, or when state law interferes with the objectives of federal law.
In product liability, conflict preemption often arises when a company can’t change a product’s design or label without FDA approval. The U.S. Supreme Court has recognized this principle in cases like PLIVA, Inc. v. Mensing (2011), which barred failure-to-warn claims against generic drug manufacturers because they are required to use the same labels as their brand-name counterparts.
Florida has a robust product liability system designed to hold manufacturers accountable for defective products. Plaintiffs can bring claims based on:
Defective design
Manufacturing defects
Failure to warn or inadequate labeling
However, when federal law applies, preemption can block one or all of these claims.
A leading case, Riegel v. Medtronic, Inc. (2008), established that PMA-approved medical devices are protected from most state-law claims. The Supreme Court held that because the FDA had reviewed and approved the design, labeling, and manufacturing process of the device, state tort claims imposing different standards were preempted.
For Florida plaintiffs, this means that lawsuits involving PMA medical devices—like certain heart stents or defibrillators—often face dismissal unless they fit into a narrow exception.
In Wyeth v. Levine (2009), the Supreme Court ruled that failure-to-warn claims against brand-name drug manufacturers were not preempted because the manufacturer could unilaterally strengthen warnings through the FDA’s “changes being effected” (CBE) process.
However, in PLIVA v. Mensing, the Court reached the opposite result for generic drugs, finding preemption because generic manufacturers cannot alter FDA-approved labels.
Thus, under Florida law, whether a pharmaceutical case survives often depends on whether the product was brand-name or generic—and whether the manufacturer had authority to change its warnings.
While federal preemption most often arises in drug and device cases, it also appears in automotive defect and consumer product litigation.
The National Traffic and Motor Vehicle Safety Act gives NHTSA authority to set safety standards for vehicles.
In Geier v. American Honda Motor Co. (2000), the Supreme Court held that a claim alleging a car was defective because it lacked airbags was preempted. NHTSA’s goal was to give manufacturers flexibility to introduce safety features gradually, and a state tort claim would have undermined that policy.
Florida plaintiffs alleging automotive defects must therefore ensure their claims do not conflict with federal safety objectives or design flexibility policies.
Products regulated by the CPSC, such as children’s toys or household appliances, may also trigger preemption. However, preemption is less common here unless a specific federal standard directly addresses the defect in question.
Consumer Products
Although federal preemption is a powerful defense, it is not absolute. There are several ways skilled Florida product liability attorneys can challenge it.
A “parallel claim” is a state-law claim that mirrors a federal requirement rather than conflicts with it. For example, if a manufacturer violates FDA regulations regarding product testing or reporting, a plaintiff can argue that the company failed to comply with both federal and state law.
Courts have held that such claims are not preempted because they do not impose additional or conflicting requirements—they simply enforce existing federal obligations.
If a manufacturer fails to follow FDA-approved procedures or conceals information from regulators, preemption may not apply. Claims based on fraud, misbranding, or noncompliance can sometimes survive because they allege conduct outside the scope of federal approval.
Even when a product initially received federal approval, ongoing misconduct—like failing to update warnings when new risks emerge—can create liability. Plaintiffs may assert that the manufacturer violated duties that coexist with federal requirements.
Sometimes, insurers downplay how much coverage is available by misstating policy limits. They may suggest there’s only a small amount of coverage — hoping you’ll settle for less.
However, there could be additional policies or umbrella coverage that apply, such as:
Employer or commercial insurance (for company vehicles)
Uninsured/underinsured motorist coverage
Third-party liability
Your attorney can investigate all possible sources of compensation to ensure no coverage is left on the table.
Florida courts tend to follow federal precedent on preemption but also emphasize consumer protection under Florida Statutes § 768.81 and related case law.
However, Florida plaintiffs should be aware that preemption challenges are often raised early in litigation, through motions to dismiss or summary judgment. Successfully navigating these challenges requires detailed knowledge of both federal regulatory frameworks and Florida tort law.
Working with an experienced Florida product liability attorney—like those at Sahil Vijay Law, PLLC—is critical. The firm understands how to frame claims to fit within recognized exceptions and ensure that injured consumers get their day in court.
Federal preemption can bar Florida product liability claims when federal law occupies the field or conflicts with state law.
Commonly affected areas include medical devices, pharmaceuticals, and motor vehicles.
Plaintiffs may overcome preemption through parallel claims or by alleging violations of federal law.
Legal strategy and precise pleading are essential to keeping cases in state court.
Federal preemption represents one of the most complex and powerful defenses in product liability litigation. For Florida consumers, it can mean the difference between a successful claim and a dismissed case.
At Sahil Vijay Law, PLLC, our attorneys are dedicated to holding negligent manufacturers accountable—even when federal law appears to stand in the way. We analyze every case carefully to identify exceptions, build parallel claims, and protect the rights of injured Floridians.
If you or a loved one has been harmed by a defective product in Florida, contact Sahil Vijay Law, PLLC today for a free consultation. Let us help you understand your options and pursue the justice you deserve.
Disclaimer: This article provides general information and should not be construed as legal advice. You should consult with an attorney for guidance on their specific circumstances.
If you would like to speak to an attorney at Sahil Vijay Law, PLLC, please click here.
When Floridians are injured by a defective product—whether a medical device, automobile, or household item—they often turn to product liability law to seek justice. But even when a product causes clear harm, one powerful legal concept can bar recovery: federal preemption.
Federal preemption occurs when federal law overrides or “preempts” state laws, meaning a state-based claim cannot proceed because it conflicts with federal regulation. In the context of Florida product liability claims, preemption can significantly limit a consumer’s ability to recover damages from a manufacturer.
This article explains what preemption is, how it applies in Florida product claims, and what injured consumers should know when federal law stands in the way of justice.
The Supremacy Clause of the U.S. Constitution (Article VI, Clause 2) establishes that federal law is the “supreme law of the land.” When Congress enacts legislation that occupies a specific field, or when federal regulations conflict with state laws, the federal rule takes priority.
In the context of product liability, preemption arises when products are regulated by federal agencies such as:
The Food and Drug Administration (FDA) – for drugs, medical devices, and food.
The National Highway Traffic Safety Administration (NHTSA) – for motor vehicles.
The Consumer Product Safety Commission (CPSC) – for consumer products.
If these agencies impose comprehensive federal standards, manufacturers may argue that they cannot be sued under state law because doing so would conflict with federal oversight.
Courts recognize three main types of preemption relevant to Florida product claims:
This occurs when Congress explicitly states in a statute that federal law preempts state law.
For example, the Medical Device Amendments (MDA) to the Food, Drug, and Cosmetic Act (FDCA) contain an express preemption clause. It bars states from imposing requirements “different from or in addition to” federal requirements for medical devices that received premarket approval (PMA).
If a pacemaker or hip implant has PMA from the FDA, a Florida plaintiff may be prevented from suing the manufacturer under traditional state law theories, like negligence or strict liability.
Implied preemption arises when federal regulation is so comprehensive that it “occupies the field” and leaves no room for state law—or when compliance with both federal and state law is impossible.
For example, if the FDA has strict labeling requirements for a prescription drug, a plaintiff cannot claim that the manufacturer should have used a different label unless that label was FDA-approved. Doing so would directly conflict with federal law.
This occurs when complying with both state and federal law is impossible, or when state law interferes with the objectives of federal law.
In product liability, conflict preemption often arises when a company can’t change a product’s design or label without FDA approval. The U.S. Supreme Court has recognized this principle in cases like PLIVA, Inc. v. Mensing (2011), which barred failure-to-warn claims against generic drug manufacturers because they are required to use the same labels as their brand-name counterparts.
Florida has a robust product liability system designed to hold manufacturers accountable for defective products. Plaintiffs can bring claims based on:
Defective design
Manufacturing defects
Failure to warn or inadequate labeling
However, when federal law applies, preemption can block one or all of these claims.
A leading case, Riegel v. Medtronic, Inc. (2008), established that PMA-approved medical devices are protected from most state-law claims. The Supreme Court held that because the FDA had reviewed and approved the design, labeling, and manufacturing process of the device, state tort claims imposing different standards were preempted.
For Florida plaintiffs, this means that lawsuits involving PMA medical devices—like certain heart stents or defibrillators—often face dismissal unless they fit into a narrow exception.
In Wyeth v. Levine (2009), the Supreme Court ruled that failure-to-warn claims against brand-name drug manufacturers were not preempted because the manufacturer could unilaterally strengthen warnings through the FDA’s “changes being effected” (CBE) process.
However, in PLIVA v. Mensing, the Court reached the opposite result for generic drugs, finding preemption because generic manufacturers cannot alter FDA-approved labels.
Thus, under Florida law, whether a pharmaceutical case survives often depends on whether the product was brand-name or generic—and whether the manufacturer had authority to change its warnings.
While federal preemption most often arises in drug and device cases, it also appears in automotive defect and consumer product litigation.
The National Traffic and Motor Vehicle Safety Act gives NHTSA authority to set safety standards for vehicles.
In Geier v. American Honda Motor Co. (2000), the Supreme Court held that a claim alleging a car was defective because it lacked airbags was preempted. NHTSA’s goal was to give manufacturers flexibility to introduce safety features gradually, and a state tort claim would have undermined that policy.
Florida plaintiffs alleging automotive defects must therefore ensure their claims do not conflict with federal safety objectives or design flexibility policies.
Products regulated by the CPSC, such as children’s toys or household appliances, may also trigger preemption. However, preemption is less common here unless a specific federal standard directly addresses the defect in question.
Although federal preemption is a powerful defense, it is not absolute. There are several ways skilled Florida product liability attorneys can challenge it.
A “parallel claim” is a state-law claim that mirrors a federal requirement rather than conflicts with it. For example, if a manufacturer violates FDA regulations regarding product testing or reporting, a plaintiff can argue that the company failed to comply with both federal and state law.
Courts have held that such claims are not preempted because they do not impose additional or conflicting requirements—they simply enforce existing federal obligations.
If a manufacturer fails to follow FDA-approved procedures or conceals information from regulators, preemption may not apply. Claims based on fraud, misbranding, or noncompliance can sometimes survive because they allege conduct outside the scope of federal approval.
Even when a product initially received federal approval, ongoing misconduct—like failing to update warnings when new risks emerge—can create liability. Plaintiffs may assert that the manufacturer violated duties that coexist with federal requirements.
Florida courts tend to follow federal precedent on preemption but also emphasize consumer protection under Florida Statutes § 768.81 and related case law.
However, Florida plaintiffs should be aware that preemption challenges are often raised early in litigation, through motions to dismiss or summary judgment. Successfully navigating these challenges requires detailed knowledge of both federal regulatory frameworks and Florida tort law.
Working with an experienced Florida product liability attorney—like those at Sahil Vijay Law, PLLC—is critical. The firm understands how to frame claims to fit within recognized exceptions and ensure that injured consumers get their day in court.
Federal preemption can bar Florida product liability claims when federal law occupies the field or conflicts with state law.
Commonly affected areas include medical devices, pharmaceuticals, and motor vehicles.
Plaintiffs may overcome preemption through parallel claims or by alleging violations of federal law.
Legal strategy and precise pleading are essential to keeping cases in state court.
Federal preemption represents one of the most complex and powerful defenses in product liability litigation. For Florida consumers, it can mean the difference between a successful claim and a dismissed case.
At Sahil Vijay Law, PLLC, our attorneys are dedicated to holding negligent manufacturers accountable—even when federal law appears to stand in the way. We analyze every case carefully to identify exceptions, build parallel claims, and protect the rights of injured Floridians.
If you or a loved one has been harmed by a defective product in Florida, contact Sahil Vijay Law, PLLC today for a free consultation. Let us help you understand your options and pursue the justice you deserve.
Disclaimer: This article provides general information and should not be construed as legal advice. You should consult with an attorney for guidance on their specific circumstances.
If you would like to speak to an attorney at Sahil Vijay Law, PLLC, please click here.
424 E Central Blvd
Unit 651
Orlando, FL 32801
A transactional law firm headquartered in Orlando, Florida.
